Status:
COMPLETED
Individualized Studies of Triggers of Paroxysmal Atrial Fibrillation
Lead Sponsor:
University of California, San Francisco
Conditions:
Atrial Fibrillation Paroxysmal
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The I-STOP-Afib study will test the comparative effectiveness of using N-of-1 trials vs. symptom surveillance alone to reduce Atrial Fibrillation (AF) episode frequency and severity and improve qualit...
Detailed Description
N-of-1 Trial arm: Participants will use the Eureka mobile application and AliveCor device to execute at least one N-of-1 trial with the goal of identifying and better controlling their AF triggers. Ea...
Eligibility Criteria
Inclusion
- symptomatic paroxysmal AF
- a smartphone
Exclusion
- Non-English speakers
- Children (age \< 18 years)
- Patients with plans to substantially change AF management (such as with ablation or change in antiarrhythmic drugs) over the ensuing 6 months
- Unwillingness to test AF triggers.
- Patients who have had an AV node or AV Junction ablation
Key Trial Info
Start Date :
March 20 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 3 2020
Estimated Enrollment :
499 Patients enrolled
Trial Details
Trial ID
NCT03323099
Start Date
March 20 2019
End Date
April 3 2020
Last Update
November 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, San Francisco
San Francisco, California, United States, 94143